We compared measures of ID coronary atherosclerosis between diabetic and non-diabetic patients enrolled in a prospective multinational IVUS registry. The region of interest was the most diseased 10 mm segment of a single coronary artery. Coronary plaque was quantified using greyscale IVUS and further classified by phenotype (ID-adaptive intimal thickening, ID-pathological intimal thickening, ID-TCFA, ID-fibroatheroma, or ID-fibrocalcific) using VH-IVUS. There was a non-significant trend for greater total plaque volume in diabetic (n5191) compared with non-diabetic (n5584) patients (94.8 vs. 88.1 mm 3 , p50.36, adjusted for multiple comparisons). There was a greater proportion of ID-TCFA among diabetic patients (21.6 vs. 13.6%, p50.01 after adjustment for multiple comparisons; p50.08 following multivariable adjustment for age and clinical demographics), while differences in pathological intimal thickening, fibroatheroma and fibrocalcific plaque were not significant between groups. ID-TCFA was more common in the most diseased 10 mm segment of diabetic than in non-diabetic coronary arteries. Multivariable adjustment demonstrated age and possibly the presence of diabetes to be independent predictors of ID-TCFA.
Introduction
Diabetes is associated with premature mortality, vascular morbidity and an excessive risk for acute MI [1] [2] [3] . Children diagnosed with diabetes, compared with non-diabetic persons, are expected to have a life expectancy shortened by as much as 20 years. 3 There is evidence that coronary atherosclerosis occurs in diabetic patients at a relatively young age, 1 ,4, 5 and it has been estimated that the age of transition to high cardiovascular risk occurs approximately 15 years earlier (age 40) in diabetic than in non-diabetic patients. 6 Although vascular risk among diabetic patients has been extensively described 1, [6] [7] [8] [9] it remains incompletely understood. Histopathology findings from victims of sudden cardiac death demonstrate differences in the constituents of diabetic and non-diabetic plaque, including increased total plaque burden and necrotic tissue. 10 Others 11 have also demonstrated an association between higher haemoglobin A 1C levels, increased fatty streaks and lesions in the right coronary artery in young adults, suggesting earlier development of atherosclerosis in diabetic subjects.
Original article sudden cardiac death). Identification of TCFA is now possible using emerging cardiovascular IVUS imaging technology. Using VH-assisted IVUS, atherosclerotic lesions can be characterised according to presence of fibrous, fibrofatty, dense calcium and necrotic tissue 14 and further classified by ID phenotype (ID-adaptive intimal thickening, ID-pathological intimal thickening, ID-TCFA, ID-fibroatheroma or ID-fibrocalcific).
Given this prior body of work, we postulate that differences exist between diabetic and non-diabetic patients in the quantity and/or composition of coronary atherosclerosis. Since limited data are available on the phenotypic classification of atherosclerosis in living diabetic subjects, the objective of this study was to describe the proportion of five major plaque phenotypes (ID-adaptive intimal thickening, ID-pathological thickening, ID-TCFA, ID-fibroatheroma, and ID-fibrocalcific) in diabetic and non-diabetic patients enrolled in a prospective, multinational IVUS registry.
Methods
Subjects were enrolled during 2004-2006 in the VH-IVUS Global Registry, a prospective registry at 37 multinational centres. Patients underwent coronary angiography followed by IVUS at the discretion of the operator for one or more indications: (1) assessment of an indeterminate lesion, (2) investigation of a culprit lesion for optimal device sizing, (3) post-stent assessment, or (4) clarification of extent of disease. There were 775 patients with analyzable IVUS images of native coronary vessels, pullback length greater than 10 mm, and complete clinical and laboratory values. Each enrolling centre's institutional review board approved this study and obtained informed consent from each subject.
Qualitative analysis was performed according to the American College of Cardiology expert consensus on IVUS. 15 Plaque volume was derived using the Trapezoidal 16 rule within the defined segment as follows: (external elastic membrane volume -lumen volume). Diabetes was determined by reported history or by the presence of active treatment (pharmacologic or diet). Acute coronary syndromes were classified as unstable angina, non-ST-elevation MI, or ST-elevation MI according to American College of Cardiology/American Heart Association guidelines. 17 Vessels were imaged with 20 MHz IVUS catheters (Eagle Eye ® Gold, Volcano Corp., Rancho Cordova, CA, USA) during continuous motorised pullback at 0.5 mm/s (R-100 TM and TrakBack ® II, Volcano Corp.). Software (pcVH V2.2, Volcano) was used to calculate geometric and composition data for each IVUS frame. VH-IVUS is a validated 14, [18] [19] [20] method that uses the mathematical technique of autoregressive modelling to classify the IVUS radiofrequency data into one of four colour-coded plaque components for human coronary atherosclerosis: (1) fibrous (green), (2) fibrofatty (light-green), (3) dense calcium (white), and (4) necrotic core (red).
VH-IVUS borders were drawn by technicians at the Cleveland Clinic Department of Biomedical Engineering (Cleveland, OH, USA) or the Cardiovascular Research Foundation (New York, NY, USA) and verified at Cardialysis-Erasmus Research Lab (Rotterdam, The Netherlands). Analyses of the medial-adventitial and luminal borders were performed in each analysable cross-sectional frame for the entire pullback length.
Patients undergoing single-vessel IVUS during diagnostic catheterisation or before percutaneous coronary intervention were included in this analysis. The IVUS region of interest was the most diseased 10 mm segment, identified by summarising plaque volume in contiguous cross sections over an axial distance of 10 mm. The segment with the greatest plaque volume constituted the most diseased 10 mm.
VH-IVUS frames were assigned a phenotype using an automated pixel detection algorithm (Volcano Corp.) based on a modified histopathology classification scheme developed by Virmani et al. 12 (figure 1) and expert consensus guidelines for analysing and interpreting VH-IVUS images. 21 Interobserver variability in phenotypic classification is removed by the algorithm. Confluence for each compositional element was set at a minimal area for this study. A confluent area was defined as a circular area represented by continuous composition of the same tissue type for a minimum diameter of approximately 12 pixels or 0.08 mm 2 on a 400 3 400 VH-IVUS image. All phenotype definitions are specific to a 400 3 400 VH-IVUS image transcribed by the pcVH software.
Demographic data were analysed using Student's t-tests for continuous and c 2 tests for categorical data. Plaque volume and phenotypes are represented as median (IQR). Comparisons between diabetic status were performed using Wilcoxon Rank-Sum tests adjusting the p-values for multiple comparisons using a bootstrap method. 22 Since the ID-TCFA phenotype held significance after the multiple comparison adjustment, a multivariable generalised linear model was developed using a Gamma distribution and Log link function. Demographic elements with p-values ≤ 0.10 (age, gender, hypertension, heart failure, dyslipidaemia and current smoking) were included in the model to adjust for differences in diabetic status. The relationship between age and ID-TCFA by diabetes status was graphically depicted. Statistical significance was defined as p ≤ 0.05. Analyses were conducted using SAS Version 9.1 (SAS Institute, Cary, NC, USA).
Results
Baseline characteristics stratified by diabetes are shown in table 1. As expected there were differences between diabetic and non-diabetic patients, including presence of hypertension, dyslipidemia, congestive heart failure, LDL cholesterol, triglycerides and systolic blood pressure. Overall, median (IQR) plaque volume within the most diseased 10 mm segment was greater in diabetic than in non-diabetic patients; however, the difference was not statistically significant ( A multivariable model including age, diabetes, gender, hypertension, heart failure, dyslipidaemia and current smoking was used to determine the factors independently associated with ID-TCFA frequency. Age (p < 0.0001) and possibly diabetes (p50.08) were independently associated with ID-TCFA. The relationship between age, diabetes and ID-TCFA is shown in figure 2 . By age strata, the frequency of ID-TCFA was numerically greater in the diabetic group. There was no significant age-diabetes interaction (p50.52).
Discussion
In this multinational IVUS registry including patients with suspected or known coronary artery disease and undergoing coronary angiography, diabetic patients did not have greater plaque volume but did have a significantly greater proportion of plaque classified as ID-TCFA in the most diseased 10 mm segment compared with non-diabetic patients. Following multivariable adjustment, age and possibly diabetes were the only independent predictors of ID-TCFA. The multivariable model demonstrated that the proportion of ID-TCFA was numerically greater for diabetic patients of any given age. These data suggest that differences in the frequency of plaque phenotypes may be relevant in understanding the biology of diabetic atherosclerosis and in estimating future cardiovascular risk in this very high-risk population.
Diabetes is a coronary risk equivalent 1 conferring a risk of an index MI comparable to that of non-diabetic patients with previous MI. It has been suggested that diabetes results in accelerated vascular aging, resulting in a transition to high risk for vascular events 15 years earlier than in non-diabetic patients. 6 While preliminary, our findings on the relationship between age and ID-TCFA plaque in diabetic patients may be relevant to the vascular aging process of diabetic subjects, although this finding will require further study.
These findings extend the work of others. TCFA lesions are characterised by a fibrous cap thickness less than 65 µm, a large area of confluent necrotic core underlying the fibrous cap and loss of smooth muscle cells with a prominent inflammatory infiltrate, and have been studied in sudden cardiac death victims. In a histopathologic investigation of the coronary arteries from sudden coronary death Figure 2 . Mean percentage of ID-TCFA by age and diabetes, adjusted for gender, hypertension, heart failure, dyslipidemia and smoking. The age by diabetes interaction was not significant (p50.52) subjects, Burke et al. found more necrotic core in type 1 and 2 diabetic subjects than age, race and gender-matched non-diabetic subjects. 10 In a VH-IVUS study of 90 patients with stable angina, Nasu et al. found a significantly greater proportion of ID-TCFA in diabetic compared with nondiabetic patients. 23 Consistent with this finding, we found living diabetic patients had a greater proportion of ID-TCFA. In an autopsy study consisting of 200 sudden death cases, 60% of acute thrombi were from TCFA rupture. 12 In addition to histopathologic studies, previous greyscale IVUS studies provide complementary insights into plaque morphometry. Symptomatic plaque rupture does not occur at minimal disease segments but rather at areas containing large plaque accumulation in larger arteries with expansive remodelling. In a study of 112 ruptured plaques using greyscale IVUS, Fujii and colleagues found that over 95% had at least three of the following five morphometric features: (1) large EEM CSA (>14.3 mm 2 ), (2) lumen CSA greater than 8.1 mm 2 , (3) minimal plaque thickness greater than 1.6 mm, (4) plaque burden > 63%, and (5) remodelling index > 0.87. 24 In fact, the mean plaque burden of symptomatic plaque rupture is 76%. 25 However, these features do not consistently lead to lumen compromise; significant diameter stenosis is highly variable in plaques that rupture or have these morphometric features.
After establishing that ID-TCFA was more common in diabetic patients, we sought to determine whether the mere presence or absence of diabetes was independently associated with the frequency of ID-TCFA. While age was an important driver, diabetes, as a dichotomous variable, was of marginal, non-statistical significance. This does not diminish the nearly two-fold greater ID-TCFA frequency among diabetic patients. It does, however, suggest that the presence of diabetes is not likely to be an exclusive factor driving the presence of ID-TCFA. This finding deserves further study. Future model variables not available in this database, yet of interest, would include the degree of glycaemic control, diabetes duration, markers of insulin resistance and inflammation.
We believe that using IVUS to characterise plaque by phenotype improves identification of atherosclerosis but recognise several limitations. Although IVUS plaque phenotyping allows one to describe an IVUS frame on the basis of composition, its confluence and the relationship of these elements to the lumen and vessel wall, it is not identical to histopathologically defined phenotypes. For example, cap thickness of histopathologically derived TCFA is less than 65 µm, which is beyond the resolution of current IVUS imaging platforms. Secondly, histopathologic sections visualise an axial distance of 4 µm, compared with approximately 300 µm on VH-IVUS. Lastly, no consensus definition currently exists for ID-phenotypes. Although IVUS-and histopathologic-TCFA are not equivalent, the IVUS-based plaque phenotyping criteria were derived from a simplified plaque-classification system developed from histopathologic observations in sudden cardiac death subjects ranging from early lesion development (ID-adaptive intimal thickening), intermediate-developed plaque (ID-pathological intimal thickening) and advanced plaque phenotypes (ID-TCFA, ID-fibroatheroma and IDfibrocalcific). 12 Further, our analysis consisted of one vessel per patient, thus we cannot exclude the presence of important sampling bias. However, consistent with methods from other IVUS studies, we analysed the most diseased 10 mm arterial segment using objective criteria to identify it within the IVUS pullback region. Finally, the cross-sectional design of our study prohibits establishment of a conclusive relationship between ID-TCFA frequency, diabetes and future risk of sudden cardiac death or non-fatal MI. A prospective longitudinal study is required to test this association.
In conclusion, diabetes patients did not have significantly greater plaque but did have a nearly two-fold greater proportion of ID-TCFA in the worst 10 mm segment. The independent factors associated with this finding are yet to be determined. This observation in living patients is novel and may provide insight into the increased risk for complications of atherosclerosis among persons with diabetes mellitus.
Acknowledgements
We thank Jose Aceituno and Joseph Murphy for publication assistance.
Declaration of Conflicting Interests
SPM is a consultant for Volcano Corporation and Novo Nordisk, and has received research grants from Volcano Corp., Boston Scientific, Amylin Pharmaceuticals, and The Medicines Company. PM is an employee of Volcano Corp. The remaining authors declare that they have no conflicts of interest.
Funding
Supported in part by a grant from the American Diabetes Association Amaranth Diabetes Fund and Volcano Corporation. 
